The significantly shorter OS in patients with high RAC1 mRNA expression indicates the significant role of Rac1 in MM treatment, supporting our in vitro findings of the role of Rac1 in MM cell survival and drug sensitivity. The gene discussed is RAC1; the disease is Miyoshi myopathy.